NeuroTone
On sale on the US market (according to the DSLD)
Douglas Laboratories, food supplement from the US market
NeuroTone (Douglas Laboratories), a food supplement au code-barres 745287200704, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Douglas Laboratories
- Barcode
- 745287200704
- Form
- Tablet
- One serving
- 4 tablets
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Hydroxypropyl Cellulose, Silica, Stearate, Croscarmellose Sodium, Stearic Acid, Soy Lecithin, Hypromellose, Glycerin, Vanilla Flavor, Natural
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Choline | Vitamin | 150 mg |
| Acetyl-L-Carnitine Hydrochloride | Other substance | 500 mg |
| L-Glutamine | Amino acid | 500 mg |
| L-Pyroglutamic Acid | Other substance | 250 mg |
| L-Tyrosine | Amino acid | 250 mg |
| Eleutherococcus senticosus dried extract (Eleutherococcus senticosus) | Plant | 150 mg |
| Ashwagandha root extract (Withania somnifera) | Plant | 150 mg |
| DMAE Bitartrate | Other substance | 100 mg |
| Ginkgo biloba Leaf Extract | Plant | 80 mg |
| Phosphatidylserine | Fat | 50 mg |
| Docosahexaenoic Acid | Fatty acid | 42 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: NeuroTone
Entered into DSLD on 23 October 2020. Withdrawn from the US market on 9 September 2021 (according to the DSLD).- Same quantity, different name: Acetyl-L-Carnitine HCl in this version; Acetyl-L-Carnitine Hydrochloride on the displayed label (500 mg)
Official label: NeuroTone
Entered into DSLD on 24 February 2017. Withdrawn from the US market on 14 August 2020 (according to the DSLD).- Active ingredient added : Acetyl-L-Carnitine HCl (500 mg)
- Active ingredient added : Glutamine (500 mg)
- Active ingredient removed : Acetyl-L-Carnitine Hydrochloride (500 mg)
- Active ingredient removed : L-Glutamine (500 mg)
- Same quantity, different name: Choline Bitartrate in this version; Choline on the displayed label (150 mg)
- Same quantity, different name: Tyrosine in this version; L-Tyrosine on the displayed label (250 mg)
Official label: NeuroTone
Entered into DSLD on 25 July 2012. Withdrawn from the US market on 16 December 2016 (according to the DSLD).- Active ingredient added : Ashwagandha Root and Leaves (150 mg)
- Active ingredient added : Eleutherococcus Senticosus (150 mg)
- Active ingredient added : Lecithin (250 mg)
- Active ingredient added : Phosphatidylcholine (65 mg)
- Active ingredient added : Phosphatidylethanolamine (50 mg)
- Active ingredient added : Phosphatidylinositol (35 mg)
- Active ingredient added : Tyrosine (250 mg)
- Active ingredient removed : Ashwagandha root extract (150 mg)
- Active ingredient removed : Eleutherococcus senticosus dried extract (150 mg)
- Active ingredient removed : L-Tyrosine (250 mg)
- Same quantity, different name: DMAE in this version; DMAE Bitartrate on the displayed label (100 mg)
- Same quantity, different name: Ginkgo Biloba Leaf in this version; Ginkgo biloba Leaf Extract on the displayed label (80 mg)
- Same quantity, different name: Glutamine in this version; L-Glutamine on the displayed label (500 mg)
Official label: NeuroTone
Entered into DSLD on 23 February 2012. Withdrawn from the US market on 20 January 2012 (according to the DSLD).- Active ingredient added : Ashwagandha Root and Leaves (150 mg)
- Active ingredient added : Eleutherococcus Senticosus (150 mg)
- Active ingredient added : Lecithin (250 mg)
- Active ingredient added : Phosphatidylcholine (65 mg)
- Active ingredient added : Phosphatidylethanolamine (50 mg)
- Active ingredient added : Phosphatidylinositol (35 mg)
- Active ingredient added : Tyrosine (250 mg)
- Active ingredient removed : Ashwagandha root extract (150 mg)
- Active ingredient removed : Eleutherococcus senticosus dried extract (150 mg)
- Active ingredient removed : L-Tyrosine (250 mg)
- Same quantity, different name: DMAE in this version; DMAE Bitartrate on the displayed label (100 mg)
- Same quantity, different name: Ginkgo Biloba Leaf in this version; Ginkgo biloba Leaf Extract on the displayed label (80 mg)
- Same quantity, different name: Glutamine in this version; L-Glutamine on the displayed label (500 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- L-Glutamine
Read the warning, when it applies and the studies cited
L-Glutamine
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Eleutherococcus senticosus dried extract
Read the warning, when it applies and the studies cited
ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS
Route of administration: Oral (ESCOP 2003; Bradley 1992)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
Contraindications
Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).
Sources cited by Health Canada (5)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
- Ashwagandha root extract
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
- Phosphatidylserine
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Douglas Laboratories
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.